The admission follows a report by the Inspector General's Office (OIG) last July probing "irregularities" by the Federal Bureau of Investigation lab.
The OIG's report found that that the flawed forensics were used in at least 60 capital punishment cases, including three in which the defendants were put to death.
In a statement acknowledging the flawed forensics, the FBI said it is "committed to ensuring that affected defendants are notified of past errors and that justice is done in every instance."
It added that the FBI "is also now employing mitochondrial-DNA hair analysis in addition to microscopic analysis."
The statement, co-signed by the Department of Justice, added that "the department and FBI have devoted considerable resources to this effort and will continue to do so until all of the cases are addressed."
The OIG's report last July criticized "the use of scientifically unsupportable analysis and overstated testimony by FBI Lab examiners in criminal prosecutions."
The daily wrote that flawed FBI forensic evidence was used at almost every trial at which it presented evidence over the course of more than 20 years.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
